Oscar Health (NYSE:OSCR – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Wednesday, February 5th. Analysts expect the company to announce earnings of ($0.55) per share and revenue of $2.47 billion for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Oscar Health (NYSE:OSCR – Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the company posted ($0.29) EPS. The business’s revenue was up 68.3% compared to the same quarter last year. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Oscar Health Stock Up 0.2 %
Shares of OSCR stock opened at $16.34 on Wednesday. The stock’s 50 day simple moving average is $15.20 and its 200 day simple moving average is $16.82. Oscar Health has a twelve month low of $12.43 and a twelve month high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market capitalization of $4.04 billion, a price-to-earnings ratio of -272.27, a PEG ratio of 0.65 and a beta of 1.70.
Analyst Ratings Changes
Insider Activity
In other Oscar Health news, CFO Richard Scott Blackley sold 25,279 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $457,044.32. Following the sale, the chief financial officer now owns 881,841 shares of the company’s stock, valued at $15,943,685.28. The trade was a 2.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the transaction, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders purchased 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. 25.11% of the stock is owned by company insiders.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
- Five stocks we like better than Oscar Health
- 3 Dividend Kings To Consider
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Use the MarketBeat Excel Dividend Calculator
- What Does the Future Hold for Eli Lilly?
- Why Invest in High-Yield Dividend Stocks?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.